Rating History for Ascendis Pharma (ASND) by Barclays

More Stocks Rated by Barclays | Latest Ratings for ASND
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/28/2026 Eliana Merle New Coverage Overweight
(N/A)		 342.00
(N/A)		 233.65
(240.65)		 3% Details